The Mifepristone Case and the Legitimacy of the FDA
Gluck A. The Mifepristone Case and the Legitimacy of the FDA. JAMA 2023, 329: 2121-2122. PMID: 37266955, DOI: 10.1001/jama.2023.8712.Peer-Reviewed Original ResearchAbortion, InducedFemaleHumansMifepristoneMisoprostolPregnancyUnited StatesUnited States Food and Drug Administration